Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs BETA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH BETA DRUGS PROCTER & GAMBLE HEALTH/
BETA DRUGS
 
P/E (TTM) x 34.6 - - View Chart
P/BV x 10.6 10.2 103.3% View Chart
Dividend Yield % 2.0 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   BETA DRUGS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Jun-23
BETA DRUGS
Mar-23
PROCTER & GAMBLE HEALTH/
BETA DRUGS
5-Yr Chart
Click to enlarge
High Rs5,3661,024 523.8%   
Low Rs3,883546 711.1%   
Sales per share (Unadj.) Rs740.7236.3 313.4%  
Earnings per share (Unadj.) Rs138.232.0 432.4%  
Cash flow per share (Unadj.) Rs155.242.8 362.5%  
Dividends per share (Unadj.) Rs95.000-  
Avg Dividend yield %2.10-  
Book value per share (Unadj.) Rs447.6127.9 350.1%  
Shares outstanding (eoy) m16.609.61 172.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.23.3 187.8%   
Avg P/E ratio x33.524.6 136.1%  
P/CF ratio (eoy) x29.818.4 162.4%  
Price / Book Value ratio x10.36.1 168.2%  
Dividend payout %68.70-   
Avg Mkt Cap Rs m76,7617,549 1,016.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,062171 1,207.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m12,2962,271 541.4%  
Other income Rs m1848 2,439.0%   
Total revenues Rs m12,4802,279 547.7%   
Gross profit Rs m3,247531 611.1%  
Depreciation Rs m281104 269.9%   
Interest Rs m824 31.9%   
Profit before tax Rs m3,142411 765.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m847103 819.6%   
Profit after tax Rs m2,295307 747.0%  
Gross profit margin %26.423.4 112.9%  
Effective tax rate %27.025.2 107.1%   
Net profit margin %18.713.5 138.0%  
BALANCE SHEET DATA
Current assets Rs m11,7131,344 871.7%   
Current liabilities Rs m6,791697 974.2%   
Net working cap to sales %40.028.5 140.6%  
Current ratio x1.71.9 89.5%  
Inventory Days Days26311 2,411.8%  
Debtors Days Days3431,008 34.1%  
Net fixed assets Rs m10,617695 1,526.8%   
Share capital Rs m16696 172.7%   
"Free" reserves Rs m7,2651,133 641.3%   
Net worth Rs m7,4311,229 604.7%   
Long term debt Rs m070 0.0%   
Total assets Rs m22,3302,039 1,095.1%  
Interest coverage x409.118.0 2,272.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.1 49.4%   
Return on assets %10.316.2 63.5%  
Return on equity %30.925.0 123.5%  
Return on capital %42.433.5 126.6%  
Exports to sales %012.3 0.0%   
Imports to sales %13.10.2 5,888.0%   
Exports (fob) Rs mNA278 0.0%   
Imports (cif) Rs m1,6055 31,853.2%   
Fx inflow Rs m1,465278 526.1%   
Fx outflow Rs m1,60548 3,347.4%   
Net fx Rs m-140231 -60.8%   
CASH FLOW
From Operations Rs m2,360234 1,009.3%  
From Investments Rs m-215-191 112.7%  
From Financial Activity Rs m-985-25 3,980.2%  
Net Cashflow Rs m1,16018 6,306.0%  

Share Holding

Indian Promoters % 0.0 66.7 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 20.0 0.4 5,547.2%  
FIIs % 6.2 0.3 1,950.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 33.3 144.8%  
Shareholders   56,778 2,116 2,683.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Procter & Gamble Health vs BETA DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Procter & Gamble Health vs BETA DRUGS Share Price Performance

Period Procter & Gamble Health BETA DRUGS S&P BSE HEALTHCARE
1-Day -0.43% -2.87% 0.45%
1-Month -1.15% 7.25% 2.55%
1-Year 0.73% 73.66% 56.14%
3-Year CAGR -8.76% 95.14% 15.22%
5-Year CAGR 4.97% 61.51% 19.63%

* Compound Annual Growth Rate

Here are more details on the Procter & Gamble Health share price and the BETA DRUGS share price.

Moving on to shareholding structures...

The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of BETA DRUGS the stake stands at 66.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of BETA DRUGS .

Finally, a word on dividends...

In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.

BETA DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of BETA DRUGS .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.